The National Institute for Health and Clinical Excellence (NICE) is the independent body that advises the government about which treatments should be available through the NHS. It has issued guidance to doctors about the drugs used to treat ADHD.
NICE says that three drugs can be used for ADHD. These are methylphenidate, atomoxetine and dexamfetamine. A specialist doctor should be the one to decide if a child needs to take drugs for ADHD. But once Read the rest of this entry »

Jan. 26, 2009 — Treatment-related hallucinations and other psychotic symptoms in children with attention deficit hyperactivity disorder (ADHD) may be more common than previously thought, FDA officials report in the latest issue of the journal
Pediatrics.
In an earlier investigation, FDA researchers identified more than 850 separate incidences of hallucinations and other psychotic episodes among children taking stimulants used to treat ADHD.
Read the rest of this entry »

Nov. 19, 2008 –
,
, and
do not appear to cause genetic damage in children who take them for attention deficit hyperactivity disorder (ADHD), a new government-funded study concludes.
The findings should reassure parents concerned that the stimulant drugs used to treat ADHD may be linked to an increased risk of
.
taking Ritalin.
The new study, conducted by researchers from the National Institutes of Health and Duke University Medical Read the rest of this entry »

ADHD Drugs Can Cause Children To Hallucinate, FDA Says
January 27, 2009 6:48 a.m. EST
Miami, FL (AHN) – Children being treated with medication for attention deficit hyperactivity disorder suffer through hallucinations and psychotic symptoms at a higher rate than previously thought, a new study suggests.
The study by the U.S. Food and Drug Administration identified more than 850 instances where children being treated for ADHD with drugs like Read the rest of this entry »

Injuries in very young children are associated with later diagnosis of attention deficit hyperactivity disorder, UK research suggests.
A study of 62,000 children shows both head and burn injuries before the age of two are linked with almost double the risk of ADHD diagnosis by age 10.
It suggests injuries in general are an early sign of ADHD behaviour.
The British Medical Journal study may help GPs spot children who need specialist referral, Read the rest of this entry »

(RTTNews) - 
Wednesday, Novartis Pharmaceuticals Corp., a subsidiary of Novartis AG (NVS:
), said that it received US Food and Drug Administration, or FDA, approval for a 30-minute onset of action for its Focalin extended release capsules used in the treatment of Attention Deficit Hyperactivity Disorder, or ADHD.
According to the company, the FDA labeling was based on the clinical study data of 86 ADHD affected Read the rest of this entry »

attention-deficit disorder drug has gotten the pharmaceutical company in trouble with the Food and Drug Administration.
Last week, the FDA issued a warning letter to Shire — a Basingstoke, England, company that has its U.S. headquarters in Chester County — in which it told Shire to pull the plug on the video.
Shire spokesman Matt Cabrey said the video in question, which features former company spokesman Ty Pennington of the “Extreme Read the rest of this entry »